Skip to main content
OpenTrials

Clinical trial condition

Thyroid Neoplasms

Explore clinical trials studying Thyroid Neoplasms. Study availability and eligibility vary by location and protocol.

519 public trials 124 recruiting studies
Refine in advanced search Browse all conditions

Thyroid Neoplasms trial results

Active, Not Recruiting

Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations

NCT04521686

Conditions
Adenocarcinoma, Any Solid Tumor, Astrocytoma, +49 more
Locations
  • Mayo Clinic of Scottsdale Phoenix, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • USC Norris Cancer Hospital Los Angeles, California, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
View all 33 locations
View Trial Details
Active, Not Recruiting

Evaluating the Combination of Everolimus and Sorafenib in the Treatment of Thyroid Cancer

NCT01141309

Conditions
Endocrine Gland Neoplasms, Endocrine System Diseases, Head and Neck Neoplasms, +5 more
Locations
  • Memorial Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States
  • Memorial Sloan Kettering Westchester Harrison, New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Active, Not Recruiting

Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial

NCT04284774

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine Gland Neoplasms, Endocrine System Diseases, +102 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
View all 172 locations
View Trial Details
Active, Not Recruiting

Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer

NCT04238624

Conditions
Anaplastic Thyroid Cancer, BRAF Gene Mutation, BRAF Mutation-Related Tumors, +12 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation

NCT07023731

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adnexal Diseases, +61 more
Locations
  • Clinical Trial Site Phoenix, Arizona, United States
  • Clinical Trial Site Phoenix, Arizona, United States
  • Clinical Trial Site New Haven, Connecticut, United States
  • Clinical Trial Site Tampa, Florida, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

NCT02834013

Conditions
Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
View all 1007 locations
View Trial Details

Related conditions